Select Page

Happy Holidays!

by | Aug 14, 2020

Today, BioPharma is able to attract global pharma and biotech companies to Canada in order to conduct critical studies like CNS, Antisense, Addiction and Oncology. These global clients are now being exposed to the incubator environment created by the Canadian government and they too can reap the rewards of Canadian Innovation and Technology.

In order to further incentivise early-stage research and clinical trials in Canada, the government’s Scientific Research and Experimental Development (SR&ED) program, each year, provides over $4 billion in investment tax credits to over 18,000 businesses. In fact, certain expenditures performed outside of Canada are also considered in the program. Businesses involved in research or in advancing technology to improve or develop devices, materials, products or processes may be eligible under the program.

But tax credits are not the only incentive Canada offers for clinical research. It was a Canada-based epidemiologist who played a crucial role in the development of the Consolidated Standard of Reporting Trials (CONSORT), which has been adopted by over 500 health care journals worldwide. Canada is home to over 40 research hospitals, 15 research universities and 17 faculties of medicine, naturally making it a world leader in terms of expertise among most developed nations.

Time is another major consideration for clinical trials. In 2002, Canadian authorities reduced regulatory roadblocks and review times for clinical trial applications. Currently, applications are generally cleared within 30 days, sooner than most countries in the world. In the US, the IND process can delay the start of Early Phase I programs, while in Europe, it can take up to 60 days or more to obtain such an approval. Canada’s CTA process does not require an IND or IMPD for clinical trial approval. In fact, data from Phase I studies conducted in Canada has and can be submitted to support a client’s IND submission to the US FDA.

Looking at the benefits mentioned above, it’s no surprise that Canada attracts about 4 per cent of the world’s clinical trials and is a leader with a strong reputation in biomedical research.

Despite all efforts made, many critics say that the programs and incentives in place have not yet given birth to a unicorn in the sector. However, with the cooperation of the government and research sponsors, clinical research organizations do have a lot of potential to expand and make Canada one of the most sought after research locations in the world. While other markets continue to seek the same investments, Canada is continuously developing on its quality standards, research and regulations.

Greater collaboration among international drug developers and Canadian contract research organizations will undoubtedly lead to the faster development of life-changing medications which have the ability to transform millions of lives.

_______________

About BioPharma Services Inc.

BioPharma Services Inc. is a full-service Contract Research Organization (CRO) specializing in the conduct of Phase I/IIa and Bioequivalence clinical trials for international pharmaceutical companies worldwide. BioPharma has clinical facilities both in the USA and Canada with a total capacity of 300 beds with access to healthy volunteers and special populations. Headquartered in Toronto, Canada, BioPharma’s comprehensive services also include Bioanalysis at our GLP Certified Laboratory, Scientific and Regulatory Affairs, Biostatistics and Safety Data Analysis (CDISC), Data Management and Medical Writing.

Popular Posts

What are early phase clinical trials?

Clinical Trials are divided into 4 phases.  Phase 1 and 2 trials constitute early phase trials, Phase 3 and 4 research studies are late-phase trials.

The primary objective of Phase 1 studies is to determine the correct drug dosage by evaluating drug safety and determining if there are any side effects.  Phase 1 trials are conducted in healthy volunteers.

Phase 2 studies also study the safety of a drug but focus on evaluating its effectiveness. These studies can be conducted in healthy volunteers or in individuals who have a certain disease or condition.

What is a clinical trial?

A Clinical trial is a process which is performed to determine whether an investigational drug, device or therapy is safe and effective.   In early phase research (i.e. Phases 1 and 2), the safety and effectiveness of the drug will be evaluated in healthy volunteers.

What is an investigational drug?

An investigational drug can also be called an experimental drug and is being studied to see if your disease or medical condition improves while taking it. Scientists are trying to prove in clinical trials:

  • If the drug is safe and effective.
  • How the drug might be used in that disease.
  • How much of the drug is needed.
  • Information about the potential benefits and risks of taking the drug.
Why do you need to take blood draws and how many blood draws will be required?

In order to evaluate the drug profile, we need to understand its pharmacokinetics. This is essentially how the body reacts to a drug after its administration through the mechanisms of absorption, distribution, as well as the metabolic changes. Therefore, blood draws are collected at various time points to better understand this mechanism. Each study requires a specific number of blood draws and total blood volume. These values will be provided to you and clearly stipulated in the informed consent form (ICF). The amount of blood that will be taken is outlined in the ICF.

Should I expect to experience any side-effects while doing studies?

As every study is testing an investigational product, there may be side effects. You will be provided with a list of side effects that have been reported in previous trials (if any), so you can make an informed decision whether or not to participate in the trial. During the trial you will be required to immediately inform clinic study staff of any adverse effects that you are experiencing. These side effects usually resolve upon discontinuation of the study drug.

Will I be compensated for doing a clinical study?

Volunteers are compensated and the amount varies depending on the length of the clinical trial, length of stay and number of follow-up visits. The compensation is not specifically related to the risks or type of drug involved in the trials or studies. Every study is different and therefore, the compensation will vary. Study volunteers may receive between $1000 to $4000 for a trial (based on the factors listed above).

Are food and accommodation provided over the course of the trial?

Food – Clinical trials are conducted in a controlled setting which means that all food is provided and  trial volunteers receive standardised meals.  Individual meal plans or meal preferences cannot be provided.  If you have any food allergies or hypersensitivity to food product(s) that are clinically significant or life-threatening you may not be able to participate in a trial.    Please contact us to discuss any food issues.

Accommodation – During your in-clinic stay you will share sleeping areas with other volunteers who are of the same gender.  Similar to a hospital setting, supervision will be provided to ensure that your health and safety are being monitored.

What is the length of a study and do I have to complete all the visits?

Details of the duration of a study can be found on the Volunteer Hub.

What is informed consent and how is it carried out?

Before you decide whether or not to take part in a clinical research study, you will be required to read and understand the information provided in an Informed Consent Form (ICF).  The ICF describes the clinical research study and the nature of the investigational product to be used, including:

  • Your rights and responsibilities as a study participant.
  • What you will be asked to do during study participation.
  • The potential risks that you should be aware of.

During this process, you will have the opportunity to discuss and ask questions related to the conduct of the clinical research study with the study doctor/ study staff.  You are under no obligation to participate and your decision to take part in a clinical trial is voluntary.

Can I bring my own food?

All aspects of clinical trials are closely monitored including the food and drink consumed by participants. While you are in the clinic, you will be provided with all meals as per the study guidelines. You will need to eat all the food provided to ensure the guidelines are met. Watch video

When do I receive compensation for taking part in a study?

You will receive compensation as outlined during the Informed Consent process. Typically, you will receive compensation once all study visits have been completed. If, for any reason, you do not complete all study visits, your compensation will be on a pro-rated basis (i.e. for the time that you have participated in the trial)

Where will I sleep during the clinical study?

We provide a clean, safe socially distance sleeping environment, in a dormitory of hotel room style. Watch video

What COVID-19 precautions are you taking?

The safety of our volunteers is a top priority. Learn more about the measures we are taking to create a safe environment for you.

Can I bring my own device?

Yes, we encourage you to bring items that will help to pass the time while you are in the clinic. You can use the time to study or work or catch up on the movies you’ve been meaning to watch.

Privacy

We respect and value the privacy of our volunteers. View our Privacy and Cookie Policy here.